Buchumschlag

Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer

Aim: to evaluate prognostic and predictive value of surface-cells markers — CD44 and CD24 in the primary tumour tissue and after neoadjuvant chemotherapy (NACT) in different groups of patients of breast cancer (BC). Object and methods: specimens ofthe primary tumour and sp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Онкологія
Datum:	2018
1. Verfasser:	Ryspayeva, D.E.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2018
Schlagworte:	Оригинальные исследования
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/145305
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer / D.E. Ryspayeva // Онкологія. — 2018. — Т. 20, № 1. — С. 23-27. — Бібліогр.: 32 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
von: D. E. Ryspayeva
Veröffentlicht: (2018)

Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
von: Ryspayeva, D.E., et al.
Veröffentlicht: (2017)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
von: S. M. Hrybach, et al.
Veröffentlicht: (2018)

Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: S. V. Chekhun, et al.
Veröffentlicht: (2015)

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: Chekhun, S.V., et al.
Veröffentlicht: (2015)

Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
von: I. P. Nesina, et al.
Veröffentlicht: (2019)

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
von: Lyalkin, S.A., et al.
Veröffentlicht: (2023)

Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
von: Timovska, Yu.O., et al.
Veröffentlicht: (2009)

Estimation of content of CD44+CD24– cells as additional criterion of efficiency of preventive therapy in experiment at oncopathology
von: N. A. Bondarovich, et al.
Veröffentlicht: (2008)

Prognostic value of blood redox-state indicators in patients with breast cancer
von: A. P. Burlaka, et al.
Veröffentlicht: (2018)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
von: D. Y. Tsyhyka, et al.
Veröffentlicht: (2013)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
von: Tsyhyka, D.Y., et al.
Veröffentlicht: (2013)

Topoisomerase IIα determins the prognosis and response to chemotherapy in patients with operable breast cancer
von: D. E. Ryspaeva, et al.
Veröffentlicht: (2017)

Features of hepcidin expression in patients with breast cancer
von: Yu. Lukianova, et al.
Veröffentlicht: (2015)

Определение содержания CD44⁺CD24⁻ клеток как дополнительный критерий оценки эффективности превентивной терапии онкопатологии в эксперименте
von: Бондарович, Н.А., et al.
Veröffentlicht: (2008)

The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
von: Liubota, R., et al.
Veröffentlicht: (2017)

Secondary edematous breast cancer: when to be operated on background of neo-adjuvant chemotherapy?
von: O. M. Bilyi, et al.
Veröffentlicht: (2019)

Expression of anti-apoptothic protein survivin and gene BIRC5 in primary breast carcinoma as a prognostic marker for progression of disease
von: Ya. A. Shliakhtunou
Veröffentlicht: (2018)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

Characterization of breast cancer DNA content profiles as a prognostic tool
von: B. I. Gerashchenko, et al.
Veröffentlicht: (2014)

Characterization of breast cancer DNA content profiles as a prognostic tool
von: Gerashchenko, B.I., et al.
Veröffentlicht: (2014)

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
von: S. Akyurek, et al.
Veröffentlicht: (2013)

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
von: Akyurek, S., et al.
Veröffentlicht: (2013)

Interplay of host genome and tumour genome in bladder cancer
von: M. P. Smal, et al.
Veröffentlicht: (2019)

Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Second-line chemotherapy in patients with advanced gastric cancer
von: V. G. Bondar, et al.
Veröffentlicht: (2014)

Combination of chemotherapy and immunotherapy in cancer patients treatment (review)
von: N. E. Prokhach, et al.
Veröffentlicht: (2017)

Expression of epithelial-mesenchymal transition-related genes in prostate tumours
von: Gerashchenko, G.V., et al.
Veröffentlicht: (2017)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: O. V. Shepil, et al.
Veröffentlicht: (2014)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: Shepil, O.V., et al.
Veröffentlicht: (2014)

Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
von: Buchynska, L.G., et al.
Veröffentlicht: (2009)

Human microbiota and effectiveness of cancer chemotherapy
von: Shvets, Yu.V., et al.
Veröffentlicht: (2023)

Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
von: N. O. Verovkina, et al.
Veröffentlicht: (2017)

Quality of life of patients with ovarian cancer after cytoreductive surgery and chemotherapy
von: A. I. Rybin, et al.
Veröffentlicht: (2018)

Analysis of the efficacy of combination treatment of ovarian cancer patients with neoadjuvant chemotherapy
von: A. A. Mikhanovskij, et al.
Veröffentlicht: (2014)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
von: Kryzhanivska, A.E., et al.
Veröffentlicht: (2018)

Heterogeneity of premetastatic niches gene expression in breast cancer cells
von: L. A. Tashireva, et al.
Veröffentlicht: (2015)

Heterogeneity of premetastatic niches gene expression in breast cancer cells
von: Tashireva, L.A., et al.
Veröffentlicht: (2015)

Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
von: Kirkilevsky, S.I., et al.
Veröffentlicht: (2023)